Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Sep;65(9):3719–3724. doi: 10.1128/iai.65.9.3719-3724.1997

Binding of Pasteurella haemolytica leukotoxin to bovine leukocytes.

J F Brown 1, F Leite 1, C J Czuprynski 1
PMCID: PMC175530  PMID: 9284143

Abstract

Pasteurella haemolytica is the principal bacterial pathogen in the bovine respiratory disease complex. This organism produces an exotoxin (referred to as leukotoxin) during logarithmic-phase growth that is a potent leukocyte-modulating agent. At low concentrations, it activates neutrophils and mononuclear phagocytes to release inflammatory mediators, while at the same time making these cells destined to undergo apoptotic cell death. At higher concentrations, the toxin causes rapid swelling and loss of cell viability. In this study, we demonstrated that toxin binding can be directly evaluated by flow cytometry with biologically active biotinylated leukotoxin. Leukotoxin binding was blocked by the addition of a neutralizing anti-leukotoxin monoclonal antibody and was not detected when bovine leukocytes were incubated with culture filtrates from a mutant strain of P. haemolytica that does not produce biologically active leukotoxin. In addition, treatment of bovine leukocytes with protease K eliminated subsequent binding of leukotoxin, suggesting that there is a protein on the leukocyte surface that is either a leukotoxin binding site or is required for stabilization of leukotoxin binding. We did not detect binding of biotinylated leukotoxin to porcine or human leukocytes, which have been reported previously to be resistant to the lytic effects of the leukotoxin. These findings suggest that there may be a specific binding site for P. haemolytica leukotoxin on bovine but not on porcine or human leukocytes and that it might be involved in the activation and lytic activities of the leukotoxin.

Full Text

The Full Text of this article is available as a PDF (140.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baluyut C. S., Simonson R. R., Bemrick W. J., Maheswaran S. K. Interaction of Pasteurella haemolytica with bovine neutrophils: identification and partial characterization of a cytotoxin. Am J Vet Res. 1981 Nov;42(11):1920–1926. [PubMed] [Google Scholar]
  2. Bauer M. E., Welch R. A. Association of RTX toxins with erythrocytes. Infect Immun. 1996 Nov;64(11):4665–4672. doi: 10.1128/iai.64.11.4665-4672.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Benz R., Schmid A., Wagner W., Goebel W. Pore formation by the Escherichia coli hemolysin: evidence for an association-dissociation equilibrium of the pore-forming aggregates. Infect Immun. 1989 Mar;57(3):887–895. doi: 10.1128/iai.57.3.887-895.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bhakdi S., Martin E. Superoxide generation by human neutrophils induced by low doses of Escherichia coli hemolysin. Infect Immun. 1991 Sep;59(9):2955–2962. doi: 10.1128/iai.59.9.2955-2962.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Boehm D. F., Welch R. A., Snyder I. S. Domains of Escherichia coli hemolysin (HlyA) involved in binding of calcium and erythrocyte membranes. Infect Immun. 1990 Jun;58(6):1959–1964. doi: 10.1128/iai.58.6.1959-1964.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Car B. D., Suyemoto M. M., Neilsen N. R., Slauson D. O. The role of leukocytes in the pathogenesis of fibrin deposition in bovine acute lung injury. Am J Pathol. 1991 May;138(5):1191–1198. [PMC free article] [PubMed] [Google Scholar]
  7. Chidambaram M., Sharma B., Petras S. F., Reese C. P., Froshauer S., Weinstock G. M. Isolation of Pasteurella haemolytica leukotoxin mutants. Infect Immun. 1995 Mar;63(3):1027–1032. doi: 10.1128/iai.63.3.1027-1032.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Clinkenbeard K. D., Clarke C. R., Hague C. M., Clinkenbeard P., Srikumaran S., Morton R. J. Pasteurella haemolytica leukotoxin-induced synthesis of eicosanoids by bovine neutrophils in vitro. J Leukoc Biol. 1994 Nov;56(5):644–649. doi: 10.1002/jlb.56.5.644. [DOI] [PubMed] [Google Scholar]
  9. Clinkenbeard K. D., Mosier D. A., Confer A. W. Transmembrane pore size and role of cell swelling in cytotoxicity caused by Pasteurella haemolytica leukotoxin. Infect Immun. 1989 Feb;57(2):420–425. doi: 10.1128/iai.57.2.420-425.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Confer A. W., Panciera R. J., Clinkenbeard K. D., Mosier D. A. Molecular aspects of virulence of Pasteurella haemolytica. Can J Vet Res. 1990 Apr;54 (Suppl):S48–S52. [PubMed] [Google Scholar]
  11. Cruz W. T., Young R., Chang Y. F., Struck D. K. Deletion analysis resolves cell-binding and lytic domains of the Pasteurella leukotoxin. Mol Microbiol. 1990 Nov;4(11):1933–1939. doi: 10.1111/j.1365-2958.1990.tb02042.x. [DOI] [PubMed] [Google Scholar]
  12. Czuprynski C. J., Noel E. J., Ortiz-Carranza O., Srikumaran S. Activation of bovine neutrophils by partially purified Pasteurella haemolytica leukotoxin. Infect Immun. 1991 Sep;59(9):3126–3133. doi: 10.1128/iai.59.9.3126-3133.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Czuprynski C. J., Ortiz-Carranza O. Pasteurella haemolytica leukotoxin inhibits mitogen-induced bovine peripheral blood mononuclear cell proliferation in vitro. Microb Pathog. 1992 Jun;12(6):459–463. doi: 10.1016/0882-4010(92)90009-d. [DOI] [PubMed] [Google Scholar]
  14. Dom P., Haesebrouck F., Kamp E. M., Smits M. A. NAD-independent Actinobacillus pleuropneumoniae strains: production of RTX toxins and interactions with porcine phagocytes. Vet Microbiol. 1994 Apr;39(3-4):205–218. doi: 10.1016/0378-1135(94)90158-9. [DOI] [PubMed] [Google Scholar]
  15. Eberspächer B., Hugo F., Bhakdi S. Quantitative study of the binding and hemolytic efficiency of Escherichia coli hemolysin. Infect Immun. 1989 Mar;57(3):983–988. doi: 10.1128/iai.57.3.983-988.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gentry M. J., Srikumaran S. Neutralizing monoclonal antibodies to Pasteurella haemolytica leukotoxin affinity-purify the toxin from crude culture supernatants. Microb Pathog. 1991 May;10(5):411–417. doi: 10.1016/0882-4010(91)90086-p. [DOI] [PubMed] [Google Scholar]
  17. Gerbig D. G., Jr, Cameron M. R., Struck D. K., Moore R. N. Characterization of a neutralizing monoclonal antibody to Pasteurella haemolytica leukotoxin. Infect Immun. 1992 May;60(5):1734–1739. doi: 10.1128/iai.60.5.1734-1739.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Gerbig D. G., Jr, Walker R. D., Baker J. C., Foster J. S., Moore R. N. Calcium ion involvement in the action of Pasteurella haemolytica leukotoxin. Vet Microbiol. 1989 Apr;19(4):325–335. doi: 10.1016/0378-1135(89)90098-9. [DOI] [PubMed] [Google Scholar]
  19. Henricks P. A., Binkhorst G. J., Drijver A. A., Nijkamp F. P. Pasteurella haemolytica leukotoxin enhances production of leukotriene B4 and 5-hydroxyeicosatetraenoic acid by bovine polymorphonuclear leukocytes. Infect Immun. 1992 Aug;60(8):3238–3243. doi: 10.1128/iai.60.8.3238-3243.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Hughes H. P., Campos M., McDougall L., Beskorwayne T. K., Potter A. A., Babiuk L. A. Regulation of major histocompatibility complex class II expression by Pasteurella haemolytica leukotoxin. Infect Immun. 1994 May;62(5):1609–1615. doi: 10.1128/iai.62.5.1609-1615.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Ji G. E., O'Hanley P. Epitopes of Escherichia coli alpha-hemolysin: identification of monoclonal antibodies that prevent hemolysis. Infect Immun. 1990 Sep;58(9):3029–3035. doi: 10.1128/iai.58.9.3029-3035.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. König B., Ludwig A., Goebel W., König W. Pore formation by the Escherichia coli alpha-hemolysin: role for mediator release from human inflammatory cells. Infect Immun. 1994 Oct;62(10):4611–4617. doi: 10.1128/iai.62.10.4611-4617.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Ludwig A., Jarchau T., Benz R., Goebel W. The repeat domain of Escherichia coli haemolysin (HlyA) is responsible for its Ca2+-dependent binding to erythrocytes. Mol Gen Genet. 1988 Nov;214(3):553–561. doi: 10.1007/BF00330494. [DOI] [PubMed] [Google Scholar]
  24. Maheswaran S. K., Kannan M. S., Weiss D. J., Reddy K. R., Townsend E. L., Yoo H. S., Lee B. W., Whiteley L. O. Enhancement of neutrophil-mediated injury to bovine pulmonary endothelial cells by Pasteurella haemolytica leukotoxin. Infect Immun. 1993 Jun;61(6):2618–2625. doi: 10.1128/iai.61.6.2618-2625.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Maheswaran S. K., Weiss D. J., Kannan M. S., Townsend E. L., Reddy K. R., Whiteley L. O., Srikumaran S. Effects of Pasteurella haemolytica A1 leukotoxin on bovine neutrophils: degranulation and generation of oxygen-derived free radicals. Vet Immunol Immunopathol. 1992 Jun;33(1-2):51–68. doi: 10.1016/0165-2427(92)90034-n. [DOI] [PubMed] [Google Scholar]
  26. Majury A. L., Shewen P. E. The effect of Pasteurella haemolytica A1 leukotoxic culture supernate on the in vitro proliferative response of bovine lymphocytes. Vet Immunol Immunopathol. 1991 Aug;29(1-2):41–56. doi: 10.1016/0165-2427(91)90051-d. [DOI] [PubMed] [Google Scholar]
  27. Mangan D. F., Taichman N. S., Lally E. T., Wahl S. M. Lethal effects of Actinobacillus actinomycetemcomitans leukotoxin on human T lymphocytes. Infect Immun. 1991 Sep;59(9):3267–3272. doi: 10.1128/iai.59.9.3267-3272.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Menestrina G., Mackman N., Holland I. B., Bhakdi S. Escherichia coli haemolysin forms voltage-dependent ion channels in lipid membranes. Biochim Biophys Acta. 1987 Nov 27;905(1):109–117. doi: 10.1016/0005-2736(87)90014-9. [DOI] [PubMed] [Google Scholar]
  29. Menestrina G., Moser C., Pellet S., Welch R. Pore-formation by Escherichia coli hemolysin (HlyA) and other members of the RTX toxins family. Toxicology. 1994 Feb 28;87(1-3):249–267. doi: 10.1016/0300-483x(94)90254-2. [DOI] [PubMed] [Google Scholar]
  30. Moayeri M., Welch R. A. Effects of temperature, time, and toxin concentration on lesion formation by the Escherichia coli hemolysin. Infect Immun. 1994 Oct;62(10):4124–4134. doi: 10.1128/iai.62.10.4124-4134.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Oropeza-Wekerle R. L., Muller S., Briand J. P., Benz R., Schmid A., Goebel W. Haemolysin-derived synthetic peptides with pore-forming and haemolytic activity. Mol Microbiol. 1992 Jan;6(1):115–121. doi: 10.1111/j.1365-2958.1992.tb00843.x. [DOI] [PubMed] [Google Scholar]
  32. Ortiz-Carranza O., Czuprynski C. J. Activation of bovine neutrophils by Pasteurella haemolytica leukotoxin is calcium dependent. J Leukoc Biol. 1992 Nov;52(5):558–564. doi: 10.1002/jlb.52.5.558. [DOI] [PubMed] [Google Scholar]
  33. Petras S. F., Chidambaram M., Illyes E. F., Froshauer S., Weinstock G. M., Reese C. P. Antigenic and virulence properties of Pasteurella haemolytica leukotoxin mutants. Infect Immun. 1995 Mar;63(3):1033–1039. doi: 10.1128/iai.63.3.1033-1039.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Rashid J., Weiss D. J., Bach R., Murtaugh M. Role of tissue factor in intra-alveolar fibrin deposition and coagulopathy associated with pneumonic pasteurellosis in cattle. Am J Vet Res. 1997 Jan;58(1):28–33. [PubMed] [Google Scholar]
  35. Rogel A., Hanski E. Distinct steps in the penetration of adenylate cyclase toxin of Bordetella pertussis into sheep erythrocytes. Translocation of the toxin across the membrane. J Biol Chem. 1992 Nov 5;267(31):22599–22605. [PubMed] [Google Scholar]
  36. Rowe G. E., Pellett S., Welch R. A. Analysis of toxinogenic functions associated with the RTX repeat region and monoclonal antibody D12 epitope of Escherichia coli hemolysin. Infect Immun. 1994 Feb;62(2):579–588. doi: 10.1128/iai.62.2.579-588.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Sharma S. A., Olchowy T. W., Breider M. A. Alveolar macrophage and neutrophil interactions in Pasteurella haemolytica-induced endothelial cell injury. J Infect Dis. 1992 Apr;165(4):651–657. doi: 10.1093/infdis/165.4.651. [DOI] [PubMed] [Google Scholar]
  38. Shenker B. J., Vitale L. A., Keiba I., Harrison G., Berthold P., Golub E., Lally E. T. Flow cytometric analysis of the cytotoxic effects of Actinobacillus actinomycetemcomitans leukotoxin on human natural killer cells. J Leukoc Biol. 1994 Feb;55(2):153–160. doi: 10.1002/jlb.55.2.153. [DOI] [PubMed] [Google Scholar]
  39. Shewen P. E., Wilkie B. N. Cytotoxin of Pasteurella haemolytica acting on bovine leukocytes. Infect Immun. 1982 Jan;35(1):91–94. doi: 10.1128/iai.35.1.91-94.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Shewen P. E., Wilkie B. N. Evidence for the Pasteurella haemolytica cytotoxin as a product of actively growing bacteria. Am J Vet Res. 1985 May;46(5):1212–1214. [PubMed] [Google Scholar]
  41. Slocombe R. F., Malark J., Ingersoll R., Derksen F. J., Robinson N. E. Importance of neutrophils in the pathogenesis of acute pneumonic pasteurellosis in calves. Am J Vet Res. 1985 Nov;46(11):2253–2258. [PubMed] [Google Scholar]
  42. Stevens P. K., Czuprynski C. J. Pasteurella haemolytica leukotoxin induces bovine leukocytes to undergo morphologic changes consistent with apoptosis in vitro. Infect Immun. 1996 Jul;64(7):2687–2694. doi: 10.1128/iai.64.7.2687-2694.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Stevens P., Czuprynski C. Dissociation of cytolysis and monokine release by bovine mononuclear phagocytes incubated with Pasteurella haemolytica partially purified leukotoxin and lipopolysaccharide. Can J Vet Res. 1995 Apr;59(2):110–117. [PMC free article] [PubMed] [Google Scholar]
  44. Styrt B., Walker R. D., Dahl L. D., Potter A. Time and temperature dependence of granulocyte damage by leucotoxic supernatants from Pasteurella haemolytica A1. J Gen Microbiol. 1990 Nov;136(11):2173–2178. doi: 10.1099/00221287-136-11-2173. [DOI] [PubMed] [Google Scholar]
  45. Taichman N. S., Iwase M., Lally E. T., Shattil S. J., Cunningham M. E., Korchak H. M. Early changes in cytosolic calcium and membrane potential induced by Actinobacillus actinomycetemcomitans leukotoxin in susceptible and resistant target cells. J Immunol. 1991 Nov 15;147(10):3587–3594. [PubMed] [Google Scholar]
  46. Welch R. A. Pore-forming cytolysins of gram-negative bacteria. Mol Microbiol. 1991 Mar;5(3):521–528. doi: 10.1111/j.1365-2958.1991.tb00723.x. [DOI] [PubMed] [Google Scholar]
  47. Yoo H. S., Rajagopal B. S., Maheswaran S. K., Ames T. R. Purified Pasteurella haemolytica leukotoxin induces expression of inflammatory cytokines from bovine alveolar macrophages. Microb Pathog. 1995 Apr;18(4):237–252. doi: 10.1016/s0882-4010(05)80001-4. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES